Rose, Shannon
April 2009
Clinical Lab Products;April2009, Vol. 39 Issue 4, p16
Trade Publication
The article presents the work of various drug research organizations towards early detection of cancer. It surveys a rapidly expanding portfolio of tumor markers under study which makes possible the earlier diagnosis and prompt treatment of the disease. According to the article, while $20 billion is spent yearly in therapeutic drug research for cancer, very little is spent on ways to diagnose and detect cancer early at which time it can be treated effectively and inexpensively to prevent its spread and increase the patient's chance of survival.


Related Articles

  • Detecting hypothyroidism after treatment for laryngeal or hypopharyngeal carcinomas: a nationwide survey in The Netherlands. Lo Galbo, Annalisa M.; de Bree, Remco; Lips, Paul; Leemans, C. RenĂ© // European Archives of Oto-Rhino-Laryngology;May2009, Vol. 266 Issue 5, p713 

    A survey to evaluate the management of thyroid function testing was performed in the major institutions treating head and neck cancer in The Netherlands. In July 2006, a questionnaire considering laboratory tests, selection of patients, scheme and treatment of hypothyroidism was sent to...

  • New cast for a new era: preclinical cancer drug development revisited. Herter-Sprie, Grit S.; Kung, Andrew L.; Kwok-Kin Wong // Journal of Clinical Investigation;Sep2013, Vol. 123 Issue 9, p3639 

    Molecularly targeted agents promise to revolutionize therapeutics by reducing morbidity and mortality in patients with cancer. However, despite an urgent need for more effective anticancer compounds, current preclinical drug evaluations largely fail to satisfy the demand. New preclinical...

  • Patients approve of nurse-led cancer service.  // Nursing Standard;2/11/2004, Vol. 18 Issue 22, p9 

    Reports on the results of a survey on patients' approval of nurse-led cancer service in Great Britain. Percentage of patients who preferred to have been seen by a doctor; Percentage of patient who went through the chemo cycle without being referred to a medical consultant.

  • A difficult conversation. Fleming, Anne Taylor // Self;Oct2007, Vol. 29 Issue 10, p172 

    The article discusses a survey by "SELF" magazine that reveals that 69% of readers who never had cancer say they are uncertain how to comfort someone in treatment. The survey also shows that 35% of women who have not had cancer admit the worst part of watching someone fight the disease is the...

  • Quality of life of head and neck cancer patient: validation of the European organization for research and treatment of cancer QLQ-C30 and European organization for research and treatment of cancer QLQ-H&N35 in Indian patients. Chaukar, D. A.; Das, A. K.; Deshpande, M. S.; Pai, P. S.; Pathak, K. A.; Chaturvedi, P.; Kakade, A. C.; Hawaldar, R. W.; D'Cruz, A. K. // Indian Journal of Cancer;Oct-Dec2005, Vol. 42 Issue 4, p178 

    AIMS: To present the first cross-culture validation of the European organization for research and treatment of cancer (EORTC) quality of life questionnaires, the EORTC-QLQ-C30, and the QLQ-H&N35 in India. SETTINGS AND DESIGN: These questionnaires were translated into two vernacular languages and...

  • Piperacillin-tazobactam in pediatric cancer patients younger than 25 months: a retrospective multicenter survey. Simon, A.; Lehrnbecher, T.; Bode, U.; Groll, A. H.; Tramsen, L.; Wieland, R.; Molitor, E.; Fleischhack, G.; Laws, H. J. // European Journal of Clinical Microbiology & Infectious Diseases;Nov2007, Vol. 26 Issue 11, p801 

    Piperacillin-Tazobactam (Pip-Taz) is an evidence-based empirical treatment of febrile neutropenia in adolescents and adults. No data are available in pediatric cancer patients <25 months of age. In this retrospective, multicenter data survey, the analysis focuses on safety, tolerance, and...

  • High prevalence of anaemia and limited use of therapy in cancer patients: a Belgian survey (Anaemia Day 2008). Verbeke, Natacha; Beguin, Yves; Wildiers, Hans; Canon, J.; Bries, Greet; Bosly, Andre; Belle, Simon // Supportive Care in Cancer;Jan2012, Vol. 20 Issue 1, p23 

    Objectives: The aim of this study is to provide relevant and accurate information on prevalence and treatment patterns of anaemia in Belgian cancer patients. Methods: The Anaemia Day 2008 survey was a single visit, multi-centre, non-interventional study in adult cancer patients under systemic...

  • Clinical outcomes of radiotherapy for esophageal cancer between 2004 and 2008: the second survey of the Japanese Radiation Oncology Study Group (JROSG). Nishimura, Yasumasa; Jingu, Keiichi; Itasaka, Satoshi; Negoro, Yoshiharu; Murakami, Yuji; Karasawa, Katsuyuki; Kawaguchi, Gen; Isohashi, Fumiaki; Kobayashi, Masao; Itoh, Yoshiyuki; Ariga, Takuro // International Journal of Clinical Oncology;Feb2016, Vol. 21 Issue 1, p88 

    Background: This second questionnaire-based survey was performed to determine the clinical results of definitive esophageal cancer treatment with radiotherapy (RT) or chemoradiotherapy (CRT) between 2004 and 2008. Materials/methods: Clinical results of definitive RT for patients were collected...

  • Burden of cancer in Malawi; common types, incidence and trends: National population-based cancer registry.  // BMC Research Notes;2012, Vol. 5 Issue 1, p149 

    The article focuses on a study of the nationwide cancer registry conducted in Malawi, between September and October 2010. From 2007-2010, 18,946 new cases of cancer were registered in the country. Cancer of the cervix was the commonest amongst females, standing to 45.4% of all cases. On the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics